scholarly journals Optimized cDICE for efficient reconstitution of biological systems in giant unilamellar vesicles

Author(s):  
Lori Van de Cauter ◽  
Federico Fanalista ◽  
Lennard van Buren ◽  
Nicola De Franceschi ◽  
Elisa Godino ◽  
...  

AbstractGiant unilamellar vesicles (GUVs) are often used to mimic biological membranes in reconstitution experiments. They are also widely used in research on synthetic cells as they provide a mechanically responsive reaction compartment that allows for controlled exchange of reactants with the environment. However, while many methods exist to encapsulate functional biomolecules in GUVs, there is no one-size-fits-all solution and reliable GUV fabrication still remains a major experimental hurdle in the field. Here, we show that defect-free GUVs containing complex biochemical systems can be generated by optimizing a double-emulsion method for GUV formation called continuous droplet interface crossing encapsulation (cDICE). By tightly controlling environmental conditions and tuning the lipid-in-oil dispersion, we show that it is possible to significantly improve the reproducibility of high-quality GUV formation as well as the encapsulation efficiency. We demonstrate efficient encapsulation for a range of minimal systems including a minimal actin cytoskeleton, membrane-anchored DNA nanostructures, and a functional PURE (Protein synthesis Using Recombinant Elements) system. Our optimized cDICE method displays promising potential to become a standard method in biophysics and bottom-up synthetic biology.

Soft Matter ◽  
2021 ◽  
Author(s):  
Peng Bao ◽  
Daniel A. Paterson ◽  
Sally A. Peyman ◽  
J. Cliff Jones ◽  
Jonathan A. T. Sandoe ◽  
...  

We describe a modified microfluidic method for making Giant Unilamellar Vesicles (GUVs) via water/octanol-lipid/water double emulsion droplets and encapsulation of nematic lyotropic liquid crystals (LNLCs).


ChemBioChem ◽  
2019 ◽  
Vol 20 (20) ◽  
pp. 2674-2682 ◽  
Author(s):  
Akanksha Moga ◽  
Naresh Yandrapalli ◽  
Rumiana Dimova ◽  
Tom Robinson

2021 ◽  
Author(s):  
Nicolas Dolder ◽  
Philipp Mueller ◽  
Christoph von Ballmoos

Giant unilamellar vesicles (GUVs) are micrometer-sized model membrane systems that can be viewed directly under the microscope. They serve as scaffolds for the bottom-up creation of synthetic cells, targeted drug delivery and have been used in many in vitro studies of membrane related phenomena. GUVs are also of interest for the functional investigation of membrane proteins that carry out many key cellular functions. A major hurdle to a wider application of GUVs in this field is the diversity of existing protocols that are optimized for individual proteins. Here, we compare PVA assisted and electroformation techniques for GUV formation under physiologically relevant conditions, and analyze the effect of immobilization on vesicle structure and membrane tightness towards small substrates and protons. There, differences in terms of yield, size, and leakage of GUVs produced by PVA assisted swelling and electroformation were found, dependent on salt and buffer composition. Using fusion of oppositely charged membranes to reconstitute a model membrane protein, we find that empty vesicles and proteoliposomes show similar fusion behavior, which allows for a rapid estimation of protein incorporation using fluorescent lipids.


Author(s):  
Christina Schweitzer

Pancreatic cancer is the fourth largest cause of cancer-related deaths in Canada, and has the highest mortality rate of all major cancers.  The typical methods of treatment: chemotherapy and radiation have significant side effects, as they do not target the tumour specifically.  Targeted therapies are being developed that would specifically affect the pancreatic tumour, leaving healthy cells undamaged.  A small, hydrophilic drug has been shown to inhibit the activity of Neu1 sialidase, an enzyme involved in the activation of the growth process, which is upregulated in tumour cells.  Previous research has shown that encapsulation of the drug in a surgically implanted PLGA capsule allows for drug release over a period of several weeks, inhibiting tumour growth.  A microparticle form is desired, to decrease the invasiveness of the treatment. Encapsulation of the drug was performed using an aqueous double-emulsion method, resulting in a drug encapsulation efficiency of 37%.  A mean particle size of 125  was obtained, within the range acceptable for injectable particles. Further experiments will be performed to compare the encapsulation efficiency with microparticles prepared using an organic single-emulsion method.  The release kinetics of the drug will be characterized in vitro using HPLC analysis, and its effectiveness in inhibiting tumour growth will be assessed using tumour cell cultures and animal models.  Should this dosage form prove effective at inhibiting tumour growth, it may lead to the formulation of an injectable dosage form capable of sustained release.  


Life ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 634
Author(s):  
Ylenia Miele ◽  
Gábor Holló ◽  
István Lagzi ◽  
Federico Rossi

The budding and division of artificial cells engineered from vesicles and droplets have gained much attention in the past few decades due to an increased interest in designing stimuli-responsive synthetic systems. Proper control of the division process is one of the main challenges in the field of synthetic biology and, especially in the context of the origin of life studies, it would be helpful to look for the simplest chemical and physical processes likely at play in prebiotic conditions. Here we show that pH-sensitive giant unilamellar vesicles composed of mixed phospholipid/fatty acid membranes undergo a budding process, internally fuelled by the urea–urease enzymatic reaction, only for a given range of the membrane composition. A gentle interplay between the effects of the membrane composition on the elasticity and the preferred area difference of the bilayer is responsible for the existence of a narrow range of membrane composition yielding a high probability for budding of the vesicles.


Langmuir ◽  
2021 ◽  
Vol 37 (3) ◽  
pp. 1082-1088
Author(s):  
Chiho Kataoka-Hamai ◽  
Kohsaku Kawakami

2021 ◽  
Vol 120 (3) ◽  
pp. 147a
Author(s):  
Thais A. Enoki ◽  
Haden L. Scott ◽  
Gerald W. Feigenson ◽  
Frederick A. Heberle

Sign in / Sign up

Export Citation Format

Share Document